Manufacturing & Packaging

Non‑sterile drug manufacturing includes GMP production of pharmaceutical dosage forms using validated processes, qualified equipment, and documented quality controls. Groupe PARIMA focuses on GMP manufacturing of small‑molecule non‑sterile drug products, operating under GMP-controlled process parameters aligned with local and international regulatory agencies.

Clinical supply manufacturing covers GMP production, preparation, and packaging of drug products intended for clinical trials, with appropriate documentation and quality oversight. At Groupe PARIMA, clinical supply manufacturing is executed using the same GMP discipline applied to commercial operations, supporting consistency across development and later‑stage supply.

Primary and secondary packaging services include filling, assembly, and packaging of drug products into market‑ready formats under GMP conditions. Groupe PARIMA performs primary and secondary packaging exclusively for products manufactured at its facilities, maintaining full control over packaging accuracy, integrity, and traceability.

Labeling and serialization services ensure that packaged drug products meet regulatory requirements for identification, traceability, and market distribution. Groupe PARIMA executes labeling and serialization internally in compliance with Canadian and international regulatory agencies, supporting controlled distribution and data integrity across regulated markets.